NIH-funded research R01 grant

Investigating the effects of PFAS exposure on immune health in early life

Official title: Perinatal Per- and Polyfluoroalkyl Substances (PFAS) exposure and Immunotoxicity in early life

Funded at Duke University · NIH-11019816 · Data updated 2026-11-12

This study is looking at how exposure to certain chemicals in drinking water might affect the immune health of babies and young children, especially by checking how these chemicals impact mothers during pregnancy and breastfeeding.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startApril 20, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$497,150
NIH project number5R01ES035037-03
Project IDNIH-11019816 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include pregnant women and their infants living in areas with known high levels of PFAS in drinking water.

Less likely to help

Patients who are not pregnant or do not have young children may not receive direct benefits from this research.

What this research studies

This research focuses on understanding how exposure to per- and polyfluoroalkyl substances (PFAS), particularly through contaminated drinking water, affects immune health in infants and children. The study will examine the impact of maternal PFAS exposure during pregnancy and lactation on the immune response of both mothers and their offspring. Researchers will assess changes in cellular immunity and gut microbiota, as well as the transfer of antibodies from mothers to their babies through the placenta and breast milk. By analyzing these factors, the research aims to uncover the potential immunotoxic effects of PFAS exposure in early life.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and prevention of immune-related health issues in children exposed to PFAS.

How similar studies have gone: Previous research has shown significant health risks associated with PFAS exposure, particularly regarding immune response, indicating that this area of study is both relevant and necessary.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Feng, Liping — Duke University
  • Study coordinator: Feng, Liping

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.